BioSig Technologies, Inc.

Equities

BSGM

US09073N3008

Advanced Medical Equipment & Technology

Market Closed - Nasdaq Other stock markets 16:00:00 2024-06-06 EDT			5-day change	1st Jan Change
2.02 ^USD	-0.49%		-0.49%	-57.47%

05-21	BioSig Technologies, Inc. Announces Board and Committee Appointments	CI
05-20	BioSig Technologies, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

The Methodist Hospital acquired PURE EP(TM) System from BioSig Technologies, Inc..

October 06, 2022

The Methodist Hospital acquired PURE EP(TM) System from BioSig Technologies, Inc. (NasdaqCM:BSGM) on October 7, 2022.

The Methodist Hospital completed the acquisition of PURE EP(TM) System from BioSig Technologies, Inc. (NasdaqCM:BSGM) on October 7, 2022.

Latest news about BioSig Technologies, Inc.

BioSig Technologies, Inc. Announces Board and Committee Appointments	05-21	CI
BioSig Technologies, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	05-20	CI
BioSig Technologies, Inc. Announces Board Appointments	05-03	CI
BioSig Technologies, Inc. announced that it has received $1.144164 million in funding	04-30	CI
BioSig Technologies, Inc. Appoints Anthony Amato as Chief Executive Officer	04-30	CI
BioSig Technologies, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	04-16	CI
BioSig Technologies Inc. Issues Promissory Note to an Investor for $500,000	03-12	CI
BioSig Technologies, Inc. announced that it has received $0.5 million in funding	03-06	CI
Biosig Technologies, Inc. Announces Resignation of Kenneth L. Londoner as Chief Executive Officer	02-28	CI
BioSig Technologies, Inc. Announces Executive Changes	02-28	CI
Steve Buhaly Resigns as Chief Financial Officer of Biosig Technologies, Inc	02-21	CI
Biosig Technologies, Inc. Announces Directorate Resignations	02-21	CI
BioSig Announces Reduction of its Workforce	02-20	CI
Biosig Technologies, Inc. Commences Workforce Reduction Consisted of the Departure of Sixteen Employees	02-01	CI
BioSig Technologies, Inc. Announces Executive Departures	02-01	CI
BioSig Technologies Undertaking 1-for-10 Reverse Stock Split	01-31	MT
BioSig Technologies, Inc. announced that it has received $1.04 million in funding	01-11	CI
BioSig Technologies, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-14	CI
Biosig Technologies, Inc. Appoints Fred Hrkac as Executive Vice President	11-07	CI
Mayo Clinic-Phoenix Adopts Biosig Technologies, Inc.'s New Pure EP Subscription Model	11-02	CI
Sector Update: Health Care Stocks Rise in Late Afternoon Trading	11-01	MT
Sector Update: Health Care Stocks Declining Wednesday Afternoon	11-01	MT
BioSig Technologies Receives Five New Patents Covering Digital Signal Processing Technology; Shares Rise	11-01	MT
BioSig Technologies, Inc. announced that it has received $0.597497 million in funding	23-10-24	CI
BioSig Technologies, Inc. announced that it expects to receive $0.597497 million in funding	23-10-11	CI

Chart BioSig Technologies, Inc.

Duration

Period

More charts

Company Profile

BioSig Technologies, Inc. is a medical technology company focused on deciphering the bodyâs electrical signals, starting with heart rhythms. The Companyâs product, the PURE EP Platform, a non-invasive class II device, provides real-time signal visualization allowing physicians to perform highly targeted cardiac ablation procedures. Integrating with existing systems in the EP lab, PURE EP is designed to pinpoint even the complex signals to maximize procedural success and efficiency. The PURE EP System is designed to address long-standing limitations that slow and disrupt cardiac catheter ablation procedures, such as environmental lab noise from other equipment, signal saturation, slow signal recovery, and inaccurate display of fractionated potentials. PURE EP is a signal processing platform that combines advanced hardware and software to address known challenges associated to signal acquisition, to enable electrophysiologists to see more signals and analyze them in real-time.

Sector

Advanced Medical Equipment & Technology

Calendar

2024-08-07 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

2.02 USD

Average target price

6 USD

Spread / Average Target

+197.03%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Advanced Medical Equipment & Technology

	1st Jan change	Capi.
BIOSIG TECHNOLOGIES, INC.	-57.47%	28.53M
THERMO FISHER SCIENTIFIC	+9.24%	221B
DANAHER CORPORATION	+15.84%	198B
INTUITIVE SURGICAL, INC.	+23.95%	148B
BOSTON SCIENTIFIC CORPORATION	+31.67%	112B
SIEMENS HEALTHINEERS AG	+4.68%	66.85B
EDWARDS LIFESCIENCES CORPORATION	+14.99%	52.84B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	+4.85%	50.86B
AGILENT TECHNOLOGIES, INC.	-4.47%	38.75B
GE HEALTHCARE TECHNOLOGIES INC.	-0.41%	35.15B

Other Advanced Medical Equipment & Technology